VBI Vaccines (VBIV) Misses Q1 EPS by 73c

VBI Vaccines (NASDAQ: VBIV) reported Q1 EPS of ($0.73). Revenue for the quarter came in at $1.21 million.

For earnings history and earnings-related data on VBI Vaccines (VBIV) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c